Delivery Order SPE2DB25D3022-SPE2DB25FWBQL
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,787.60 delivery order on July 14, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by October 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Nemluvio 30 mg pens, with a completion date of September 10, 2025. This delivery order contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $3,858.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nemluvio 30 mg pens with a completion date of September 9, 2025. This is a competitively awarded, non-set-aside contract with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under contract 4569086102. This firm fixed price delivery order, issued on August 13, 2025, is part of a larger indefinite delivery contract (IDC) vehicle and represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Nemluvio 30 mg pens with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBQLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens on June 6, 2025, with an ultimate completion date of June 30, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As the prime contractor under the SPE2DX vehicle, AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio under this IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. This particular delivery order for Nemluvio represents a routine pharmaceutical supply requirement within the company's broader mission to maintain medical supply chain capabilities for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 6/6/25 |